Oanh Hoang Hua

Oanh Hoang Hua

Auto-generated profile, based on publicly available information

Oanh Hoang Hua

Faculty of Traditional Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Viet Nam

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2026 in ACS Omega
Verified
Journal Article
Open access
OHOanh Hoang Hua
Oanh Hoang Hua
PTPham Minh Tu
Pham Minh Tu
NNNguyen Thi Thanh Nam
Nguyen Thi Thanh Nam
PTPham Van Tat
Pham Van Tat
Insomnia and anxiety disorders have become increasingly prevalent in modern society. The formulation study of MECS hard capsules composed of the medicinal herbs Mimosa pudica, Erythrina variegata, Cinnamomum iners, and Scoparia dulcis in an optimized weight ratio (%) of 40:12:16:32 represents a traditional Vietnamese pharmaceutical preparation. These medicinal plants have long been utilized in traditional medicine for the supportive treatment of insomnia and anxiety. This study aimed to evaluate the safety, sedative, and anxiolytic effects of MECS capsules in Swiss albino mice, while also investigating the interaction affinity of bioactive compounds from the four herbal components through in silico approaches, including molecular docking, ADMET prediction, QSAR modeling, and molecular dynamics (MD) simulations. A total of 11 potential bioactive compounds were identified through a multicriteria decision-making system. Among these, 9 compounds were confirmed in the MECS capsule using UPLC-QToF-MS chromatographic profiling, supporting the in silico screening results. Subchronic toxicity and anxiolytic effects were assessed using the light–dark box (LDB) and elevated plus maze (EPM) behavioral models, with MECS capsules administered at doses of 346 and 692 mg/kg. A sleep recovery model using diazepam was applied to evaluate the sedative properties. Toxicological assessment indicated no adverse effects at the maximum tested dose (D max) of 39 g/kg of body weight. Furthermore, no deleterious effects were observed during the 60 day subacute toxicity evaluation at either dosage level. Behavioral assessments using the LDB and EPM models demonstrated that MECS capsules reduced anxiety-related behaviors. Diazepam significantly prolonged the sleep duration and shortened sleep onset latency at both doses, confirming the sedative effect of MECS capsules. The combined evidence from docking analysis, ADMET prediction, MDs simulations, and in vivo experimentation in S. albino mice showed the MECS hard capsulesformulated from medicinal herbs with a favorable safety profileexhibited pronounced sedative and anxiolytic activities. These findings suggest that MECS capsules hold promise as a natural-origin therapeutic agent for the treatment of anxiety disorders and insomnia.

22 June 2026 in ACS Omega
Verified
Journal Article
Open access
OHOanh Hoang Hua
Oanh Hoang Hua
HTHoa Tran Thai
Hoa Tran Thai
NSNguyen Le Hoang Son
Nguyen Le Hoang Son
VHVu Le Ha
Vu Le Ha
TTTran Huyen Tran
Tran Huyen Tran
PTPham Van Tat
Pham Van Tat
The objective of this investigation is to identify and enhance compounds from the medicinal plant Erythrina variegata L. that possess potential inhibitory activity against acetylcholinesterase (AChE). Consequently, this investigation will contribute to the pursuit of supportive therapeutic agents for Alzheimer’s disease. The initial research matrix was composed of nanocluster materials that were derived from the crude extract. The identification of 13 compounds was achieved by utilizing an ultraperformance liquid chromatography system in conjunction with quadrupole time-of-flight mass spectrometry for structural elucidation. Compound VN62 was chosen due to its favorable binding energy (ES = −8.038 kcal/mol) and RMSD = 1.388 Å, as evidenced by molecular docking simulations and analytical results with the AChE protein (PDB ID: 1EVE). The pIC50 values were predicted using reliable QSAR models, such as QSARGA‑MLR, QSARGA‑ANN, and QSARKPLS‑LF, which were constructed on this basis. Five novel derivatives (VN62N1–VN62N5) were designed from VN62, subsequently semisynthesized, and structurally confirmed using spectroscopic methods, guided by QSAR and docking results. The AChE inhibitory activity was assessed in vitro, and VN62 demonstrated an IC50 of 1.34 μg/mL (pIC50 = 5.498). Conversely, the newly designed derivatives demonstrated a trend toward enhanced activity. Furthermore, a multicriteria evaluation model integrating QSAR, docking, ADMET, and quantum descriptors identified VN62N4 as the top-ranked candidate overall. Molecular dynamics simulations over 400 ns confirmed the structural stability of the VN62N4–AChE complex, as evidenced by stable RMSD, low RMSF in active-site residues, and persistent hydrogen bonding and hydrophobic interactions. The findings verify the efficacy of a comprehensive, multimethod in silico screening strategy in directing the development of AChE inhibitors.

16 April 2026 in Plant Science Today
Verified
Journal Article
Open access
PDF file
HOHoang Hua Oanh
Hoang Hua Oanh
CTChi La Thanh
Chi La Thanh
Memory impairment is a condition observed at all ages, particularly with a notably higher prevalence among the elderly, causing critical damages to both mental, physical states and daily activities. Lac Tien Thang (LTT; Vietnamese: Lạc Tiên Thang) was selected based on the convergence of traditional Vietnamese medical theory and modern pharmacological evidence in treating central nervous system disorders. Traditionally, it is used for sedative and cognition-enhancing effects, while modern studies show its flavonoid- and phenolic-rich components provide neuroprotective, antioxidant, anti-inflammatory and cognitive benefits. This study focused on investigating the memory-enhancing effects of the aqueous extract from LTT, which was evaluated in both in vitro and in vivo models to assess its inhibitory activity against acetylcholinesterase enzyme (AChE). The aqueous extract from LTT was analysed for a preliminary screening on its chemical compositions and total flavonoid quantification and inhibitory function of AChE enzyme in vitro using Ellman method as well as its memory improvement effects on Swiss albino mice following the novel object recognition test (NORT). The preliminary analysis on phytochemicals identified various components, which consisted of essential oils, triterpenoid, flavonoids, alkaloids, cardiac glycosides, polyphenols, organic acids, reducing agents and polyrunoic compounds. The total flavonoid content was 3.35 %, LTT successfully inhibited AChE activity, with an IC50 recorded at 88.95 µg/mL. The LTT extract at a dose of 2.61 g/kg presented an effective function in memory enhancing on Swiss albino mice induced memory impairment by 2.6 mg/kg of Trimethyltin chloride (TMT). Therefore, LTT extract can inhibit AchE activity and effectively improve memory in mice.

9 November 2026 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
HOHua Hoang Oanh
Hua Hoang Oanh
PQPham Ngoc Nhu Quynh
Pham Ngoc Nhu Quynh
NTNguyen Ngoc Nha Thien
Nguyen Ngoc Nha Thien
Hyperuricemia is a metabolic condition characterized by abnormally elevated uric acid levels in the body, in which xanthine oxidase (XO) plays a key role. PASA is a traditional Vietnamese polyherbal formulation comprising Cortex Phellodendri, Rhizoma Atractylodis, Herba Sarcandrae , and Herba Achyranthis asperae . The aim of this study was to evaluate the anti-hyperuricemic activity of PASA using in silico, in vitro , and in vivo approaches. Reported phytochemicals were screened by molecular docking against XO (PDB ID: 3NVY). UPLC-QTOF/MS (ESI+) was used to profile the aqueous extract and tentatively characterize its major constituents. Antioxidant activity, XO inhibitory activity, acute oral toxicity, and anti-hyperuricemic activity were evaluated in vitro and in potassium oxonate-induced hyperuricemic mice. Molecular docking identified several alkaloids and flavonoids with high predicted affinity for XO. UPLC-QTOF/MS tentatively characterized 11 major constituents in the PASA extract. PASA exhibited antioxidant activity (IC 50 = 58.00 µg/mL) and XO inhibitory activity (IC 50 = 44.43 µg/mL) and showed no acute toxicity at 27.8 g/kg. Plasma uric acid concentrations were significantly reduced in hyperuricemic mice following repeated PASA administration. Linear mixed-effects model analysis demonstrated significant effects of treatment, time, and treatment × time interaction (all p < 0.001). Both PASA doses (0.695 and 1.39 g/kg) significantly reduced plasma uric acid versus the hyperuricemic model from Day 7 onward, while the higher dose showed no significant difference from allopurinol from Day 7 onward. PASA exhibited XO inhibitory and antioxidant activities in vitro and significantly reduced plasma uric acid concentrations in hyperuricemic mice without evidence of acute toxicity. These findings support further investigation of PASA as a potential intervention for hyperuricemia.